MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready data.
Learn how we do it.
Understand HCPs’ ordering and prescribing behavior and the sentiment behind it.
Go beyond the diagnosis to understand disease progression through data such as tumor stage/sizing and histology.
Uncover hard-to-find information such as dose frequency, treatment duration and reasons for switching.
Correlate treatment patterns with HCP sentiment and behavior, payer coverage, site-of-care trends and other factors.
Through NorstellaLinQ, we have unparalleled access to rich, raw electronic medical records data, spanning 50 million U.S. lives, 2.5 billion clinical notes, more than 40 health systems and 600 hospitals, with NPI data linked back to each facility.
NorstellaLinQ combines cutting-edge artificial intelligence, natural language processing and large language model technologies to transform billions of clinical notes into structured, analyzable datasets.
Our clinical, technology, data and pharmacy experts form a cross-functional team to review and validate every AI-generated output to ensure quality, accuracy, and trust.
Revolutionize patient care by combining structured lab data with unstructured EMR notes.
Lab Data
Enhanced Insights With EMR Notes
This integration empowers HCP's to make proactive, informed decisions—positioning your productwhere it matters most and improving patient outcomes.
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
The biopharma industry’s first fully integrated data asset is paving the way for breakthroughs in commercialization.
See how MMIT, powered by NorstellaLinQ, is helping manufacturers understand the full patient journey by downloading our latest ebook.
Learn how MMIT, powered by NorstellaLinQ, helped an oncology manufacturer comb through unstructured clinical notes and surface ten times as many patients as with claims data alone.
MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
Powered by NorstellaLinQ, MMIT's HCP and Patient Targeting Solution uses structured and unstructured data to pinpoint hard-to-find patients and their treating providers.
Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.
Reducing Risk: 5 Steps for a Fearless Launch